Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth.

Petrek, Hannah; Yan Ho, Pui; Batra, Neelu; Tu, Mei-Juan; Zhang, Qianyu; Qiu, Jing-Xin; Yu, Ai-Ming

Petrek, Hannah; Yan Ho, Pui; Batra, Neelu; Tu, Mei-Juan; Zhang, Qianyu; Qiu, Jing-Xin; Yu, Ai-Ming.

Affiliation

Petrek H; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Yan Ho P; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Batra N; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Tu MJ; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Zhang Q; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Qiu JX; Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Yu AM; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA. Electronic address: aimyu@ucdavis.edu.

Biochem Pharmacol ; 189: 114392, 2021 07.

Article de En | MEDLINE | ID: mdl-33359565

Sujet(s)
Mots clés

Dual-targeting; NSCLC; Patient-derived xenograft; RNA therapy; miRNA

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Ciblage de gène / ARN non traduit / Bioingénierie / Tumeurs du poumon Limites: Animals / Humans / Male / Middle aged Langue: En Journal: Biochem Pharmacol Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google